The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances

REFERENCES

• Kline NS. Lithium comes into its own. Am J Psychiatry 1968;125:558–60.
   PubMedGoogle Scholar
• Blackwell B. Need for careful evaluation of lithium. Am J Psychiatry 1969;125:1131.
   Google Scholar
• Kline N. Need for careful evaluation of lithium. Reply. Am J Psychiatry 1969;125:1131–2.
   Google Scholar
• Jefferson J. Rediscovering the art of lithium therapy. Curr Psychiatry 2002;1:19–24.
   Google Scholar
• Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 1997;278:1745–8.
   PubMed Web of Science ®Google Scholar
• Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 1996;49:749–54.
   PubMed Web of Science ®Google Scholar
• Mayer-Gross W. Clinical psychiatry. London: Baillere, Tindall & Cassell, 1969.
   Google Scholar
• Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949;36:349–52.
   Web of Science ®Google Scholar
• Schou M, Juel-Nielsen N, Stromgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954;17:250–60.
   PubMed Web of Science ®Google Scholar
• Baastrup PC, Schou M. Prophylactic lithium? Lancet 1968;2:349–50.
   Google Scholar
• Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
   Google Scholar
• Janicak PG, Davis JM, Preskorn SH, Ayd FJ Jr. Principles and practice of psychopharmacology. Baltimore, MD: Williams & Wilkins, 1993.
   Google Scholar
• Moncrieff J. Lithium: evidence reconsidered. Br J Psychiatry 1997;171:113–9.
   PubMed Web of Science ®Google Scholar
• Johnson G, Gershon S, Hekimian LJ. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Compr Psychiatry 1968;9:563–73.
   PubMed Web of Science ®Google Scholar
• Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963;109:56–65.
   Web of Science ®Google Scholar
• Goodwin FK, Murphy DL, Bunney WE Jr. Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry 1969;21:486–96.
   PubMed Web of Science ®Google Scholar
• Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326–30.
   PubMedGoogle Scholar
• Melia PI. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621–4.
   PubMedGoogle Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082–8.
   PubMed Web of Science ®Google Scholar
• Sargant W, Slater E. An introduction to physical methods of treatment in psychiatry. London: Livingstone, 1963.
   Google Scholar
• Platman S. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970;127:351–3.
   PubMedGoogle Scholar
• Spring G, Schweid D, Gray C, Steinberg J, Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970;126:1306–10.
   PubMed Web of Science ®Google Scholar
• Librium and valium. Drug Ther Bull 1964;2:93–5.
   Google Scholar
• Chouinard G, Young SN, Annable L. Antimanic effect of clonazepam. Biol Psychiatry 1983;18:451–66.
   PubMed Web of Science ®Google Scholar
• Takezaki H, Hanaoka M. The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic-depressive states. Seishin Igaku 1971;13:173–83.
   Google Scholar
• Dalby MA. Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy. Epilepsia 1971;12:325–34.
   PubMed Web of Science ®Google Scholar
• Lambert PA, Carraz G, Borselli S, Carbel S. Neuropsychotropic action of a new anti-epileptic agent: depamide. Ann Med Psychol (Paris) 1966;124:707–10.
   Google Scholar
• Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978;2:159–75.
   PubMedGoogle Scholar
• Ballenger JC, Post RM. Carbamazepine in manic depressive illness: a new treatment. Am J Psychiatry 1980;137:782– 90.
   PubMed Web of Science ®Google Scholar
• Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: treatment of bipolar disorder 2004. Postgrad Med Spec Rep 2004;Dec:1–120.
   Google Scholar
• Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990;147:431–4.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Shelton MD, Rapport DJ, A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005;162:2152–61.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Huffman RF, White RL, Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323–33.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE Jr, Macfadden W, A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351–60.
   PubMed Web of Science ®Google Scholar
• Thase ME, Macfadden W, Weisler RH, ; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006;26:600–9.
   PubMed Web of Science ®Google Scholar
• Endicott J, Rajagopalan K, Minkwitz M, Macfadden W; BOLDER Study Group. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 2007;22:29–37.
   PubMed Web of Science ®Google Scholar
• Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537–47.
   PubMed Web of Science ®Google Scholar
• Sachs GS, Nierenberg AA, Calabrese JR, Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711–22.
   PubMed Web of Science ®Google Scholar
• Koszewska I, Rybakowski JK. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Neuropsychobiology 2009;59:12–6.
   PubMedGoogle Scholar
• Grunze HC. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr 2008;13:790–5.
   PubMedGoogle Scholar
• Licht RW, Gijsman H, Nolen WA, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008;118:337–46.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Briess D. Bipolar disorder. Clin Evid (Online) 2007 Aug 1;2007. pii: 1014.
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:1–50.
   Web of Science ®Google Scholar
• Goodwin GM. Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17:149–73.
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008;11:999–1029.
   PubMedGoogle Scholar
• Bauer MS, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry 2004;161:3–18.
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 2004;5:120–35.
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Berghöfer A, Bauer M. Bipolar disorder. Lancet. 2002;359:241–7.
   PubMed Web of Science ®Google Scholar
• Johnson G, Gershon S, Burdock EI, Floyd A, Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971;119:267–76.
   PubMed Web of Science ®Google Scholar
• Prien RF, Caffey EM, Klett CJ. Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 1972;120:409–14.
   PubMed Web of Science ®Google Scholar
• Takahashi R, Sakuma A, Itoh K, Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 1975;32:1310–8.
   PubMedGoogle Scholar
• Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 1975;32:34–42.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger AM, Swann AC, Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Depakote Mania Study Group. JAMA 1994;271:918–24.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Grunze H, Mullen J, A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 2005;66:111–21.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217–22.
   PubMed Web of Science ®Google Scholar
• Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001;(3):CD003013.
   PubMedGoogle Scholar
• Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976;133:373–8.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Murphy DL, Dunner DL, Bunney WE Jr. Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972;129:44–7.
   PubMed Web of Science ®Google Scholar
• Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 1975;32:1107–11.
   PubMed Web of Science ®Google Scholar
• Young AH, McElroy SL, Bauer M, A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010;71:150–62.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Adams D, Cahill CM, Dodd S, Berk M. The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice. Drugs 2009;69:2063–101.
   PubMed Web of Science ®Google Scholar
• Chou JC, Zito JM, Vitrai J, Craig TJ, Allingham BH, Czobor P. Neuroleptics in acute mania: a pharmacoepidemiologic study. Ann Pharmacother 1996;30:1396–8.
   PubMedGoogle Scholar
• Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE Jr. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006;67:509–16.
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger TM, McElroy SL, Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999;156:702–9.
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Grundy SL, Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000;57:841–9.
   PubMed Web of Science ®Google Scholar
• Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999;14:339–43.
   PubMed Web of Science ®Google Scholar
• Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Sommerville KW. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002;63:1148–55.
   PubMed Web of Science ®Google Scholar
• Tohen M, Ketter TA, Zarate CA, Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003;160:1263–71.
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Goodwin GM, Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J Clin Psychiatry 2008;69:1776–89.
   PubMed Web of Science ®Google Scholar
• Aitchison K, Bienroth M, Cookson J, A UK consensus on the administration of aripiprazole for the treatment of mania. J Psychopharmacol 2009;23:231–40.
   PubMed Web of Science ®Google Scholar
• Young AH, Oren DA, Lowy A, Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry 2009;194:40–8.
   PubMed Web of Science ®Google Scholar
• Keck PE, Orsulak PJ, Cutler AJ, ; CN138–135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord 2009;112:36–49.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in Mania Study Group. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003;160:741–8.
   PubMed Web of Science ®Google Scholar
• Potkin SG, Keck PE JrSegal S, Ice K, English P. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 2005;25:301–10.
   PubMed Web of Science ®Google Scholar
• Vieta E, Ramey T, Keller D, English P, Loebel A, Miceli J. Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study. J Psychopharmacol 2010; 24:547–58.
   PubMed Web of Science ®Google Scholar
• Post RM, Jimerson DC, Bunney WE Jr, Goodwin FK. Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) 1980;67:297–305.
   PubMed Web of Science ®Google Scholar
• Christie JE, Whalley LJ, Hunter R, Bennie J, Fink G. Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment. J Affect Disord 1989;16:115–20.
   Google Scholar
• Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159:1146–54.
   PubMed Web of Science ®Google Scholar
• Tohen M, Chengappa KNR, Suppes T, Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62–9.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003;182:141–7.
   PubMed Web of Science ®Google Scholar
• Sachs G, Chengappa KN, Suppes T, Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2004;6:213–23.
   PubMed Web of Science ®Google Scholar
• Tohen M, Greil W, Calabrese JR, Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281–90.
   PubMed Web of Science ®Google Scholar
• Tohen M, Calabrese JR, Sachs GS, Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006;163:247–56.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Calabrese JR, McQuade RD, ; Aripiprazole Study Group. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry 2006;67:626–37.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Calabrese JR, McIntyre RS, ; Aripiprazole Study Group. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480–91.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008;109:251–63.
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry 2009;166:476–88.
   PubMed Web of Science ®Google Scholar
• Brown EB, McElroy SL, Keck PE Jr, A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006;67:1025–33.
   PubMed Web of Science ®Google Scholar
• Brown E, Dunner DL, McElroy SL, Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. Int J Neuropsychopharmacol 2009;12:773–82.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Corya SA, Altshuler LL, Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry 2005;66:611–6.
   PubMed Web of Science ®Google Scholar
• Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord 2004;78:201–8.
   PubMed Web of Science ®Google Scholar
• Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403–8.
   PubMed Web of Science ®Google Scholar
• Clark H, Berk M, Brook S. Clonazepam vs. lithium in mania: a controlled single blind randomised trial. Hum Psychopharmacol 1997;12:325–8.
   Web of Science ®Google Scholar
• Edwards R, Stephenson U, Flewett T. Clonazepam in acute mania: a double blind trial. Aust N Z J Psychiatry 1991;25:238–42.
   PubMed Web of Science ®Google Scholar
• Aronson TA, Shukla S, Hirschowitz J. Clonazepam treatment of five lithium-refractory patients with bipolar disorder. Am J Psychiatry 1989;146:77–80.
   PubMed Web of Science ®Google Scholar
• Bowden CL. Efficacy of divalproex vs. lithium and placebo in mania. Reply. JAMA 1994;272:1006.
   Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481–9.
   PubMed Web of Science ®Google Scholar
• Gyulai L, Bowden CL, McElroy SL, Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 2003;28:1374–82.
   PubMed Web of Science ®Google Scholar
• Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003;(1):CD004052.
   Google Scholar
• Bowden CL, Swann AC, Calabrese JR, A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry 2006;67:1501–10.
   PubMed Web of Science ®Google Scholar
• Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berl) 2000;150:15–23.
   PubMed Web of Science ®Google Scholar
• Tohen M, Vieta E, Goodwin GM, Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. J Clin Psychiatry 2008;69:1776–89.
   PubMed Web of Science ®Google Scholar
• Tohen M, Baker RW, Altshuler LL, Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002;159:1011–7.
   PubMed Web of Science ®Google Scholar
• Macritchie KA GJ, Scott J, Haslam DR, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001;(3):CD003196.
   Google Scholar
• Bond DJ, Lam RW, Yatham LN. Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. J Affect Disord 2009;Dec 29 [Epub ahead of print].
   Google Scholar
• Okuma T, Inanaga K, Otsuki S, Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacology 1979;66:211–7.
   PubMed Web of Science ®Google Scholar
• Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry 1987;48:89–93.
   PubMed Web of Science ®Google Scholar
• Lusznat RM, Murphy DP, Nunn CM. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988;153:198–204.
   PubMed Web of Science ®Google Scholar
• Brown D, Silverstone T, Cookson J. Carbamazepine compared to haloperidol in acute mania. Int Clin Psychopharmacol 1989;4:229–38.
   PubMed Web of Science ®Google Scholar
• Okuma T, Yamashita I, Takahashi R, Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990;23:143–50.
   PubMed Web of Science ®Google Scholar
• Small JG, Klapper MH, Milstein V, Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry 1991;48:915–21.
   PubMed Web of Science ®Google Scholar
• Emrich HM, Dose M, Vonzerssen D. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affect Disord 1985;8:243–50.
   PubMed Web of Science ®Google Scholar
• Emrich HM. Studies with oxcarbazepine (trileptal) in acute mania. Int Clin Psychopharmacol 1990;5:83–8.
   PubMedGoogle Scholar
• Wagner KD, Kowatch RA, Emslie GJ, A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006;163:1179–86.
   PubMed Web of Science ®Google Scholar
• Okuma T, Inanaga K, Otsuki S, A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology (Berl) 1981;73:95–6.
   PubMed Web of Science ®Google Scholar
• Coxhead N, Silverstone T, Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiatr Scand 1992;85:114–8.
   PubMed Web of Science ®Google Scholar
• Simhandl C, Denk E, Thau K. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 1993;28:221–31.
   PubMed Web of Science ®Google Scholar
• Vasudev A, Macritchie K, Watson S, Geddes JR, Young AH. Oxcarbazepine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2008;(1):CD005171.
   Google Scholar
• Vieta E, Cruz N, García-Campayo J, A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Int J Neuropsychopharmacol 2008;11:445–52.
   PubMed Web of Science ®Google Scholar
• Juruena MF, Ottoni GL, Machado-Vieira R, Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:94–9.
   Google Scholar
• Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000;12:5–10.
   PubMedGoogle Scholar
• Calabrese JR, Suppes T, Bowden CL, A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000;61:841–50.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs G, ; Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013–24.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65:432–41.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60: 79–88.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE Jr, McElroy SL, Shelton MD. A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 2001;21:340–2.
   PubMed Web of Science ®Google Scholar
• Vasudev K, Macritchie K, Geddes J, Watson S, Young A. Topiramate for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev 2006;(1):CD003384.
   Google Scholar
• Frye MA, Ketter TA, Kimbrell TA, A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607–14.
   PubMed Web of Science ®Google Scholar
• Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000;2:249–55.
   PubMed Web of Science ®Google Scholar
• Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry 1999;60:759–62.
   PubMed Web of Science ®Google Scholar
• Young AH, Geddes JR, Macritchie K, Rao SN, Watson S, Vasudev A. Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability. Cochrane Database Syst Rev 2006;(3):CD004694.
   Google Scholar
• Grof P, Alda M, Grof E, Fox D, Cameron P. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Br J Psychiatry 1993;163(suppl 21):16–9.
   Google Scholar
• Passmore MJ, Garnham J, Duffy A, Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003;5:110–4.
   PubMed Web of Science ®Google Scholar
• Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House, 2005.
   Google Scholar
• Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet 2003;361:978–9.
   PubMed Web of Science ®Google Scholar